IRIS Accounts Production v26.2.5.4 07528157 Board of Directors 1.4.25 31.12.25 31.12.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075281572025-03-31075281572025-12-31075281572025-04-012025-12-31075281572024-03-31075281572024-04-012025-03-31075281572025-03-3107528157ns15:EnglandWales2025-04-012025-12-3107528157ns14:PoundSterling2025-04-012025-12-3107528157ns10:Director12025-04-012025-12-3107528157ns10:PrivateLimitedCompanyLtd2025-04-012025-12-3107528157ns10:SmallEntities2025-04-012025-12-3107528157ns10:AuditExemptWithAccountantsReport2025-04-012025-12-3107528157ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012025-12-3107528157ns10:SmallCompaniesRegimeForAccounts2025-04-012025-12-3107528157ns10:FullAccounts2025-04-012025-12-3107528157ns10:Director22025-04-012025-12-3107528157ns10:RegisteredOffice2025-04-012025-12-3107528157ns5:CurrentFinancialInstruments2025-12-3107528157ns5:CurrentFinancialInstruments2025-03-3107528157ns5:Non-currentFinancialInstruments2025-12-3107528157ns5:Non-currentFinancialInstruments2025-03-3107528157ns5:ShareCapital2025-12-3107528157ns5:ShareCapital2025-03-3107528157ns5:RetainedEarningsAccumulatedLosses2025-12-3107528157ns5:RetainedEarningsAccumulatedLosses2025-03-3107528157ns5:OwnedOrFreeholdAssetsns5:LandBuildings2025-04-012025-12-3107528157ns5:LeaseholdImprovements2025-04-012025-12-3107528157ns5:PlantMachinery2025-04-012025-12-3107528157ns5:FurnitureFittings2025-04-012025-12-3107528157ns5:MotorVehicles2025-04-012025-12-3107528157ns5:LandBuildings2025-03-3107528157ns5:LeaseholdImprovements2025-03-3107528157ns5:PlantMachinery2025-03-3107528157ns5:LandBuildings2025-04-012025-12-3107528157ns5:LandBuildings2025-12-3107528157ns5:LeaseholdImprovements2025-12-3107528157ns5:PlantMachinery2025-12-3107528157ns5:LandBuildings2025-03-3107528157ns5:LeaseholdImprovements2025-03-3107528157ns5:PlantMachinery2025-03-3107528157ns5:FurnitureFittings2025-03-3107528157ns5:MotorVehicles2025-03-3107528157ns5:FurnitureFittings2025-12-3107528157ns5:MotorVehicles2025-12-3107528157ns5:FurnitureFittings2025-03-3107528157ns5:MotorVehicles2025-03-3107528157ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3107528157ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107528157ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-12-3107528157ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3107528157ns5:Secured2025-12-3107528157ns5:Secured2025-03-3107528157ns5:DeferredTaxation2025-03-3107528157ns5:DeferredTaxation2025-04-012025-12-3107528157ns5:DeferredTaxation2025-12-31
REGISTERED NUMBER: 07528157 (England and Wales)















Unaudited Financial Statements

for the Period 1 April 2025 to 31 December 2025

for

Cenobiologics Ltd

Cenobiologics Ltd (Registered number: 07528157)






Contents of the Financial Statements
for the Period 1 April 2025 to 31 December 2025




Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 5


Cenobiologics Ltd

Company Information
for the Period 1 April 2025 to 31 December 2025







DIRECTORS: Dr M Gadri Golestani
Dr A Kazemian





REGISTERED OFFICE: Everest House Rockingham Drive
Linford Wood
Milton Keynes
MK14 6LY





REGISTERED NUMBER: 07528157 (England and Wales)





ACCOUNTANTS: Stewarts Accountants Limited
271 High Street
Berkhamsted
Hertfordshire
HP4 1AA

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Cenobiologics Ltd

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Cenobiologics Ltd for the period ended 31 December 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Cenobiologics Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Cenobiologics Ltd and state those matters that we have agreed to state to the Board of Directors of Cenobiologics Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Cenobiologics Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Cenobiologics Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Cenobiologics Ltd. You consider that Cenobiologics Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Cenobiologics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Stewarts Accountants Limited
271 High Street
Berkhamsted
Hertfordshire
HP4 1AA


21 September 2026

Cenobiologics Ltd (Registered number: 07528157)

Balance Sheet
31 December 2025

31.12.25 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 5,174,977 5,014,239

CURRENT ASSETS
Stocks 261,412 226,537
Debtors 5 806,349 940,564
Cash at bank 754,752 1,317,992
1,822,513 2,485,093
CREDITORS
Amounts falling due within one year 6 422,765 774,734
NET CURRENT ASSETS 1,399,748 1,710,359
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,574,725

6,724,598

CREDITORS
Amounts falling due after more than one
year

7

(581,939

)

(588,409

)

PROVISIONS FOR LIABILITIES 10 (448,248 ) (471,912 )
NET ASSETS 5,544,538 5,664,277

CAPITAL AND RESERVES
Called up share capital 16,656 16,656
Retained earnings 5,527,882 5,647,621
5,544,538 5,664,277

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Cenobiologics Ltd (Registered number: 07528157)

Balance Sheet - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 September 2026 and were signed on its behalf by:





Dr M Gadri Golestani - Director


Cenobiologics Ltd (Registered number: 07528157)

Notes to the Financial Statements
for the Period 1 April 2025 to 31 December 2025

1. STATUTORY INFORMATION

Cenobiologics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Improvements to property - 2% on cost
Plant and machinery - 20% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cenobiologics Ltd (Registered number: 07528157)

Notes to the Financial Statements - continued
for the Period 1 April 2025 to 31 December 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 18 (2025 - 20 ) .

4. TANGIBLE FIXED ASSETS
Improvements
Freehold to Plant and
property property machinery
£    £    £   
COST
At 1 April 2025 3,072,551 213,173 3,672,937
Additions - 320,283 321,247
Disposals - - (27,488 )
At 31 December 2025 3,072,551 533,456 3,966,696
DEPRECIATION
At 1 April 2025 254,009 - 1,813,983
Charge for period 46,089 5,923 399,558
At 31 December 2025 300,098 5,923 2,213,541
NET BOOK VALUE
At 31 December 2025 2,772,453 527,533 1,753,155
At 31 March 2025 2,818,542 213,173 1,858,954

Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 April 2025 200,910 30,940 7,190,511
Additions 31,525 - 673,055
Disposals - - (27,488 )
At 31 December 2025 232,435 30,940 7,836,078
DEPRECIATION
At 1 April 2025 77,340 30,940 2,176,272
Charge for period 33,259 - 484,829
At 31 December 2025 110,599 30,940 2,661,101
NET BOOK VALUE
At 31 December 2025 121,836 - 5,174,977
At 31 March 2025 123,570 - 5,014,239

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.3.25
£    £   
Trade debtors 608,904 316,228
Other debtors 197,445 624,336
806,349 940,564

Cenobiologics Ltd (Registered number: 07528157)

Notes to the Financial Statements - continued
for the Period 1 April 2025 to 31 December 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.3.25
£    £   
Bank loans and overdrafts (see note 8) 21,348 32,770
Trade creditors 306,117 414,667
Tax - 215,466
Social security and other taxes 14,680 15,447
Other creditors 17,571 62,975
Directors' current accounts 58,635 26,143
Accruals and deferred income 4,414 7,266
422,765 774,734

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.25 31.3.25
£    £   
Bank loans (see note 8) 80,540 87,010
Shareholders loans (see note 8) 501,399 501,399
581,939 588,409

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 80,540 87,010

8. LOANS

An analysis of the maturity of loans is given below:

31.12.25 31.3.25
£    £   
Amounts falling due within one year or on demand:
Bank loans 21,348 32,770

Amounts falling due between two and five years:
Other loans - 2-5 years 501,399 501,399

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 80,540 87,010

Cenobiologics Ltd (Registered number: 07528157)

Notes to the Financial Statements - continued
for the Period 1 April 2025 to 31 December 2025

9. SECURED DEBTS

The following secured debts are included within creditors:

31.12.25 31.3.25
£    £   
Bank loans 101,888 119,780

The bank loans are secured by way of a legal charge on the properties concerned.

10. PROVISIONS FOR LIABILITIES
31.12.25 31.3.25
£    £   
Deferred tax 448,248 471,912

Deferred
tax
£   
Balance at 1 April 2025 471,912
Provided during period (23,664 )
Balance at 31 December 2025 448,248